Dimensional Fund Advisors’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,534
Closed -$138K 3462
2023
Q3
$138K Sell
6,534
-145
-2% -$2.96K ﹤0.01% 3277
2023
Q2
$106K Sell
6,679
-862
-11% -$15.5K ﹤0.01% 3313
2023
Q1
$140K Sell
7,541
-1,215
-14% -$30.3K ﹤0.01% 3260
2022
Q4
$199 Sell
8,756
-2,273
-21% -$60.3K ﹤0.01% 3230
2022
Q3
$320K Sell
11,029
-489
-4% -$19.9K ﹤0.01% 3146
2022
Q2
$408K Sell
11,518
-6,729
-37% -$230K ﹤0.01% 3106
2022
Q1
$998K Buy
18,247
+2,931
+19% +$182K ﹤0.01% 2995
2021
Q4
$1M Buy
15,316
+10,392
+211% +$1.01M ﹤0.01% 3030
2021
Q3
$698K Buy
4,924
+3,183
+183% +$405K ﹤0.01% 3121
2021
Q2
$228K Sell
1,741
-2,092
-55% -$261K ﹤0.01% 3314
2021
Q1
$649K Buy
+3,833
New +$807K ﹤0.01% 3090

Other funds holding QTTB

Dimensional Fund Advisors's QTTB Position: Q4 2023 in Review

Dimensional Fund Advisors sold out of Q32 Bio (QTTB) in Q4 2023, closing a stake of 6,534 shares — an estimated $138K sold.

Dimensional Fund Advisors first reported a position in QTTB in Q1 2021 and held it in 11 quarters. The position peaked at $1M in Q4 2021. 57 funds tracked by Wall St. Rank hold QTTB as of Q4 2023.

  • Dimensional Fund Advisors reported no remaining Q32 Bio position as of Q4 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 6,534 Q32 Bio shares in Q4 2023, an estimated $138K.
  • Dimensional Fund Advisors first reported a position in Q32 Bio in Q1 2021 and held it in 11 quarters.
  • Dimensional Fund Advisors's Q32 Bio position peaked at $1M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2023.

Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.